Cargando…
Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom
BACKGROUND: Botulinum toxin A (BoNT-A) is an effective treatment for patients with upper limb spasticity (ULS), which is a debilitating feature of upper motor neuron lesions. BoNT-A preparations available in the UK are associated with different costs. METHODS: We developed a budget impact model to a...
Autores principales: | Abogunrin, Seye, Hortobagyi, Linda, Remak, Edit, Dinet, Jerome, Gabriel, Sylvie, Bakheit, Abdel Magid O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386804/ https://www.ncbi.nlm.nih.gov/pubmed/25878510 http://dx.doi.org/10.2147/CEOR.S76141 |
Ejemplares similares
-
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis
por: Abogunrin, Seye, et al.
Publicado: (2015) -
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review
por: Martin, Alison, et al.
Publicado: (2014) -
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
por: Muthukumar, Madhusubramanian, et al.
Publicado: (2017) -
Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013) -
Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity
por: Ghroubi, Sameh, et al.
Publicado: (2020)